The European Patent Office (EPO) has issued a patent grant, EP3521419B1, for a method and composition related to the production of brown adipocytes. The patent, which lists Murakami Yuta and Yasuhiro Yoshioka among the inventors, was granted on March 18, 2026, and applies to multiple designated states within the European Union.

This patent grant represents the finalization of intellectual property protection for the described biotechnological process. While it does not impose new regulatory obligations on companies, it signifies a new exclusive right for the patent holder in the specified jurisdictions. Companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in cell therapy or metabolic research, should be aware of this granted patent to ensure they do not infringe on the patent holder's exclusive rights.